NTRK1 and colorectal carcinoma: This study’s hypothesis is that NTRK1/2/3 expression, outside the context of gene fusion, may play biological roles in CRC, which may include influencing the clinicopathological presentation, regulation of molecular and signalling pathways and functioning as potential predictor of kinase inhibitor response in CRC.